ANTM News and Press, Anthem Inc. From 12/01/21

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of “a+” (Excellent) of the core Blue Cross Blue Shield-branded insurance subsidiaries of Anthem, Inc. (Anthem) (Indianapolis, IN) [NYSE:ANTM...

Glenn Greenberg’s 13F portfolio value decreased from $2.91B to $2.86B this quarter. Brave Warrior Advisors increased Anthem, Fidelity National Financial, and Raymond James Financial while decreasing Aon plc and dropping Dollar Tree. They also added Apollo Global. The larges...

We provide a summary of upcoming ex-dividend dates in a quick reference table. The table includes relevant data and key statistics as well as the next payout and pay date. We highlight a high-quality stock with an upcoming ex-dividend date for further research and possible investm...

Medicare Advantage insurer Clover Health’s (CLOV) shares have declined in price substantially over the past few months after hitting their record high in June, driven by the meme-stock craze. The stock is currently trading near its 52-week low. So, given the company’s low-profit...

A weekly summary of dividend activity for Dividend Champions and Contenders. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion And Contender Highlights: We...

Jeremy Grantham’s 13F portfolio value increased from $20.05B to $20.22B this quarter. GMO Capital increased Cigna and Constellation Brands while reducing Accenture plc, American Express, Alibaba Group Holding, and Baidu. The largest three individual stock positions are Micr...

A rectangle pattern has formed in the chart of Anthem (ANTM). The stock has bounced off both its resistance line and level of support. If it breaks through either level, a big move is expected. Read more to learn how to profit from this trade. Anthem ( ANTM ) is one of the largest private...

Many insurers continue to hesitate in providing coverage for Aduhelm, the recently approved medication developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALY) for Alzheimer’s disease, Bloomberg reported citing a News Survey. In the study, none of the 25 large insurers terme...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Cigna has a strong track record of growth and profitability, and Evernorth shows promise. It maintains a strong balance sheet and pays a well-covered dividend that's set for growth. It's set for robust capital returns over the next 4 years and is trading in deep value territory. ...